secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2022-11-16T23:59:59+00:00
Accession:  0000950170-22-025323
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics extends office lease through April 2024 at $93/sq ft
----------------------------------------------------------------------

- Extended lease for 22,343 sq ft in Watertown, MA from Apr 2023 to Apr 2024.
- Base rent increases to $93/sq ft/year starting May 1, 2023.
- Tenant may terminate lease after Jan 1, 2024 with 60 days' notice.
- Premises on as-is basis; no tenant improvement allowance provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000095017022025323/0000950170-22-025323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000095017022025323/lyra-20221114.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-025323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer